Following its success in early detection of cerebral ischemia, diffusion‐weighted imaging
(DWI) has been increasingly used in cancer diagnosis and treatment evaluation. These …

Glioblastoma, the most common and most rapidly progressing primary malignant tumor of
the central nervous system, continues to portend a dismal prognosis, despite improvements …

BACKGROUND AND PURPOSE: Patient survival in high-grade glioma remains poor,
despite the recent developments in cancer treatment. As new chemo-, targeted molecular …

In recent years, the development of advanced magnetic resonance imaging (MRI)
technology and machine learning (ML) have created new tools for evaluating treatment …

Background Differentiation between residual head and neck squamous cell carcinoma and
post-radiation changes is difficult with routine computed tomography and magnetic …

Background Based on conventional MRI images, it is difficult to
differentiatepseudoprogression from true progressionin GBM patients after standard …

Noninvasive imaging methods are sought to objectively predict early response to therapy for
high-grade glioma tumors. Quantitative metrics derived from diffusion-weighted imaging …

Purpose To investigate the clinical potential of pretreatment apparent diffusion coefficient
(ADC) on diffusion-weighted magnetic resonance imaging (DWI) for therapy response and …

Simple Summary MGMT-methylated glioblastomas have significantly lower ADC values, as
compared to the glioblastomas with no MGMT methylation in peritumoral white matter. There …

Background Diffusion magnetic resonance (MR) characteristics are a predictive imaging
biomarker for survival benefit in recurrent glioblastoma treated with anti-vascular endothelial …